Brief: Tetra Bio-Pharma To Submit Its PPP001 Cannabinoid-Derived Drug As A Herbal Medicinal Product To European Medicines Agency
27/03/2019 10:54
March 27 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA TO FILE PPP001 WITH THE EUROPEAN
MEDICINES
AGENCY
* TETRA BIO PHARMA INC - TO SUBMIT ITS PPP001
CANNABINOID-DERIVED
DRUG AS A HERBAL MEDICINAL PRODUCT TO EUROPEAN MEDICINES AGENCY
Source text for Eikon: ID:nGNXbX0jkm
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding